Daniela Francisci

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

Chiara Fallerini, Sergio Daga, Stefania Mantovani et al. · eLife · 2021 · 207 citations · Full text

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quirós-Roldán et al. · Journal of Antimicrobial Chemotherapy · 2016 · 75 citations · Full text

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients

Stefania Mantovani, Sergio Daga, Chiara Fallerini et al. · Genes and Immunity · 2021 · 75 citations · Full text

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

Marco Floridia, Raffaella Bucciardini, D. Ricciardulli et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1999 · 55 citations

Immunology, Pharmacotherapy, Antiviral Drug +19

Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry

Laura Galli, Maria Rita Parisi, Andrea Poli et al. · Open Forum Infectious Diseases · 2020 · 50 citations · Full text